Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,492 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NCT06914128

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • UCLA Health Bowyer Oncology Center Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco, California, United States
View all 63 locations
View Trial Details
Recruiting

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

NCT07452458

Conditions
Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +9 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 54 locations
View Trial Details
Recruiting

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

NCT06934889

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of California, Los Angeles (Data Collection Only) Los Angeles, California, United States
  • University of Miami (Data collection only) Miami, Florida, United States
  • Indiana University (Data Collection Only) Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
View Trial Details
Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

NCT05902169

Conditions
Astrocytoma, GBM, Glioblastoma, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • UCHealth Aurora, Colorado, United States
  • Mayo Clinic of Jacksonville Florida Jacksonville, Florida, United States
View all 56 locations
View Trial Details
Recruiting

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

NCT05139056

Conditions
Astrocytoma, Currently Only Enrolling Glioblastoma Patients at First Recurrence, Glioblastoma, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Standford University Stanford, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Wake Forest University Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View Trial Details
Recruiting

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 22 locations
View Trial Details

Related conditions